NCT00003449View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

June 30, 2002

Study Completion Date

February 29, 2004

Conditions
Ovarian Cancer
Interventions
DRUG

dexamethasone

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (1)

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT00003449 - Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter